
ADMA vs MRNA
$ADMA vs $MRNA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ADMA vs MRNA: trend, levels and the market
One year to 2026-11-18, against the S&P 500 (+10.6%). Split-adjusted daily closes.
- ·ADMA has the cleaner trend, above both its 50- and 200-day averages, where MRNA is above one and below the other.
- ·Only MRNA beat the market over the past year, by 679.1%, while ADMA trailed the S&P 500 at +10.6% by 24.2%.
- ·The last month has flipped the order: ADMA leads over the month (+20.7% against -18.7%) even though MRNA leads over the year.
- ·MRNA sits closer to its support, 6.7% above it at $179.56, while ADMA is 23.9% above its own at $10.32.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
ADMA vs MRNA: the quick read
- ·MRNA is the larger company by market cap ($83.68B vs $3.02B).
- ·MRNA has been more active on our scanner (341 vs 165 alerts in 30 days).
- ·ADMA has the smaller float (212.7M vs 360.3M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·ADMA trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·Both stay busy on our scanner, 341 and 165 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are not really peers by size: MRNA is more than 28x the market cap of ADMA, so the same dollar of news moves ADMA far harder.
- ·They are pulling apart today: ADMA is outperforming the other by roughly 6.5 percentage points on the session.
Objective differences only. Not investment advice.
Watching ADMA or MRNA? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ADMA and MRNA on TheDesperateTrader.
- Is ADMA or MRNA the better stock?
- "Better" depends on your goal, and these two are not alike. MRNA is the larger company by market cap ($83.68B vs $3.02B). MRNA has been more active on our scanner (341 vs 165 alerts in 30 days). ADMA has the smaller float (212.7M vs 360.3M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ADMA and MRNA?
- The differences that matter: MRNA is roughly 28x the size of the other by market cap ($3.02B vs $83.68B); they trade at very different share prices ($13.57 vs $192.47); ADMA sits at 48% of its 52-week range against 66% for MRNA; our scanner flagged ADMA 165 times in the last 30 days against 341 for MRNA. Everything above is measured from the latest completed session and SEC filings.
- Which of ADMA and MRNA is more active right now?
- Right now ADMA is at about 0.8x its normal volume and MRNA is at about 0.5x, so ADMA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is ADMA or MRNA in the stronger trend?
- ADMA is above its 50-day average of $10.82 and above its 200-day average of $10.67; MRNA is below its 50-day average of $205.61 and above its 200-day average of $98.86. MRNA leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ADMA or MRNA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ADMA and MRNA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.